You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 7,736,886


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,736,886
Title:Recombination systems and methods for eliminating nucleic acid sequences from the genome of eukaryotic organisms
Abstract: The invention relates to recombination systems and methods for eliminating nucleic acid sequences from the chromosomal DNA of eukaryotic organisms, and to transgenic organisms--preferably plants--which comprise these systems or were generated using these methods.
Inventor(s): Puchta; Holger (Karlsruhe, DE), Biesgen; Christian (Quedlinburg, DE)
Assignee: SunGene GmbH & Co. KGaA and Institut f. Pflanzengenetik u. Kulturpflanzenforschung (DE) N/A (N/A)
Application Number:10/750,891
Patent Claims:1. A recombination system comprising: a transgenic recombination construct capable of being inserted into the chromosomal DNA of a eukaryotic organism said construct comprising in a 5'- to 3'-orientation; a first homology sequence A; at least one recognition sequence for site-directed induction of DNA double-strand breaks; and a second homology sequence B, where all recognition sequences for site-directed induction of DNA double-strand breaks are located between homology sequences A and B; wherein the homology sequences A and B have at least 20 base pairs and at least 70% homology that allows for homologous recombination to each other; and an enzyme suitable for inducing DNA double-strand breaks at a recognition sequence for the site-directed induction of DNA double-strand breaks or a nucleic acid sequence encoding said enzyme; wherein after homologous recombination of homology sequences A and B the resulting transgenic sequence derived from said transgenic recombination construct does not comprise any recognition site for said enzyme suitable for inducing DNA double-strand breaks.

2. The system of claim 1, wherein the construct, after said first homology sequence, contains a further nucleic acid sequence.

3. The system of claim 2, wherein the construct further contains a second recognition sequence for the site-directed induction of DNA double-strand breaks.

4. The system of claim 2, wherein the further nucleic acid sequence contains at least one selection marker.

5. The system of claim 1, wherein the construct further contains at least one of the elements selected from the group consisting of selection markers, reporter genes, replication origins, multiple cloning regions, border sequences for Agrobacterium transfection, sequences which enable homologous recombination or insertion into a genome of a host organism, expression cassette for an enzyme suitable for inducing DNA double-strand breaks at the recognition sequence for the site-directed induction of DNA double-strand breaks and combinations thereof.

6. The system of claim 1, wherein the enzyme is selected from the group consisting of restriction endonucleases, homing endonucleases, group II intron endonucleases, recombinases, transposases, chimeric nucleases and combinations thereof.

7. The system of claim 1, wherein the enzyme is selected from the group consisting of F-SceI, F-SceII, F-SuvI, F-TevI, F-TevII, I-AmaI, I-AniI, I-CeuI, I-CeuAIIP, I,-ChuI, I-CmoeI, I-CpaI, I-CpaII, I-CreI, I-CrepsbIP, I-CrepsbIIP, I-CrepsbIIIP, I-CrepsbIVP, I-CsmI, I-CvuI, I-CvuAIP, I-DdiI, I-DdiII, I-DirI, I-DmoI, I-HmuI, I-HmuII, I-HspNIP, I-LlaI, I-MsoI, I-NaaI, I-NanI, I-NclIP, I-NgrIP, I-NitI, I-NjaI, I-Nsp236IP, I-PakI, I-PboIP, I-PcuIP, I-PcuAI, I-PcuVI, I-PgrIP, I-PobIP, I-PorI, I-PorIIP, I-PpbIP, I-PpoI, I-SPBetaIP, I-ScaI, I-Scel, I-Scell, I-SceIII, I-SceIV, I-SceV, I-SceVI, I-SceVII, I-SexIP, I-SneIP, I-SpomCP, I-SpomIP, I-SpomIIP, I-SquIP, I-Ssp6803I, I-SthPhiJP, I-SthPhiST3P, I-SthPhiS3bP, I-TdeIP, I-TevI, I-TevII, I-TevIII, I-UarAP, I-UarHGPA1P, I-UarHGPA13P, I-VinIP, I-ZbiIP, PI-MtuI, PI-MtuHIP, PI-MtuHIIP, PI-PfuI, PI-PfuII, PI-PkoI, PI-PkoII, PI-PspI, PI-Rma43812IP, PI-SPBetaIP, PI-SceI, PI-TfuI, PI-TfuII, PI-ThyI, PI-TLiI, PI-TliII and combinations thereof.

8. The system of claim 1, wherein the enzyme is selected from the group consisting of enzymes comprising the sequence as shown in SEQ ID NO: 2, 4, 6, 8 or 10, and combinations thereof.

9. The system of claim 1, wherein the enzyme is expressed from an expression cassette that contains a nucleic acid sequence encoding said enzyme.

10. The system of claim 9, wherein the nucleic acid sequence comprises the sequence as shown in SEQ ID NO: 1, 3, 5, 7 or 9.

11. A method for removing a DNA sequence from chromosomal DNA of a eukaryotic cell or organism comprising: introducing the recombination system of claim 1 into the chromosomal DNA of a eukaryotic cell or organism; inducing DNA double-strand breaks at the recognition sequence; and conducting homologous recombination between the homology sequences A and B.

12. The method of claim 11, wherein the construct contains a further nucleic acid sequence.

13. The method of claim 11, wherein the construct, after said first homology sequence A contains a second recognition sequence for the site-directed induction of DNA double-strand breaks.

14. The method of claim 11, wherein the construct contains at least one of the elements selected from the group consisting of selection markers, reporter genes, replication origins, multiple cloning regions, border sequences for Agrobacterium transfection, sequences which enable homologous recombination or insertion into a genome of a host organism, expression cassette for an enzyme suitable for inducing DNA double-strand breaks at the recognition sequence for the site-directed induction of DNA double-strand breaks and combinations thereof.

15. The method of claim 11, wherein the enzyme is selected from the group consisting of restriction endonucleases, homing endonucleases, recombinases, transposases, chimeric nucleases and combinations thereof.

16. The method of claim 11, wherein the enzyme is selected from the group consisting of F-SceI, F-SCeII, F-SuvI, F-TevI, F-TevII, I-AmaI, I-AniI, I-CeuI, I-CeuAIIP, I-ChuI, I-CmoeI, I-CpaI, I-CpaII, I-CreI, I-CrepsbIP, I-CrepsbIIP, I-CrepsbIIIP, I-CrepsbIVP, I-CsmI, I-Cvul, I-CvuAIP, I-DdiI, I-DdiII, I-DirI, I-DmoI, I-HmuI, I-HmuII, I-HspNIP, I-LlaI, I-MsoI, I-NaaI, I-NanI, I-Nc1IP, I-NgrIP, I-NitI, I-NjaI, I-Nsp236IP, I-PakI, I-PboIP, I-PcuIP, I-PcuAI, I-PcuVI, I-PgrIP, I-PobIP, I-PorI, I-PorIIP, I-PpbIP, I-PpoI, I-SPBetaIP, I-ScaI, I-SceI, I-SceII, I-SceIII, I-SceIV, I-SceV, I-SceVI, I-SceVII, I-SexIP, I-SneIP, I-SpomCP, I-SpomIP, I-SpomIIP, I-SquIP, I-Ssp6803I, I-SthPhiJP, I-SthPhiST3P, I-SthPhiS3bP, I-TdeIP, I-TevI, I-TevII, I-TevIII, I-UarAP, I-UarHGPA1P, I-UarHGPA13P, I-VinIP, I-ZbiIP, PI-MtuI, PI-MtuHIP, PI-MtuHIIP, PI-PfuI, PI-PfuII, PI-PkoI, PI-PkoII, PI-PspI, PI-Rma43812IP, PI-SPBetaIP, PI-SceI, PI-TfuI, PI-TfuII, PI-ThyI, PI-TliI, PI-TliII, and combinations thereof.

17. The method of claim 11, wherein the enzyme is selected from the group consisting of enzymes that contain the sequence as shown in SEQ ID NO: 2, 4, 6, 8 or 10, and combinations thereof.

18. The method of claim 11, wherein the enzyme is encoded in an expression cassette.

19. The method of claim 11, wherein the nucleic acid sequence comprises the sequence as shown in SEQ ID NO: 1, 3, 5, 7 or 9, or a combination thereof.

20. An organism comprising the recombination system of claim 1.

21. The organism of claim 20 selected from the group consisting of yeasts, algae, fungi and animal and plant organisms.

22. The organism of claim 21, wherein the plant organism is selected from the group consisting of Arabidopsis thaliana, tobacco, wheat, rye, barley, oats, oilseed rape, maize, potato, sugar beet, soybean, sunflower, pumpkin, squash, and peanut.

23. A cell, cell culture, organ, tissue, part or transgenic propagation material comprising the recombination system of claim 1.

24. The system of claim 2, wherein the further nucleic acid sequence comprises an expression cassette for an enzyme suitable for inducing DNA double-strand breaks at the recognition sequence for the site-directed induction of DNA double-strand breaks.

25. The system of claim 1, wherein the construct further comprises an expression cassette for an enzyme suitable for inducing DNA double-strand breaks at the recognition sequence for the site-directed induction of DNA double-strand breaks.

26. The method of claim 12, wherein the further nucleic acid sequence comprises an expression cassette for an enzyme suitable for inducing DNA double-strand breaks at the recognition sequence for the site-directed induction of DNA double-strand breaks.

27. The method of claim 11, wherein the construct comprises an expression cassette for an enzyme suitable for inducing DNA double-strand breaks at the recognition sequence for the site-directed induction of DNA double-strand breaks.

28. The recombination system of claim 1, wherein the eukaryotic organism is a plant organism.

29. The method of claim 11, wherein the eukaryotic cell or organism is a plant cell or plant organism.

Details for Patent 7,736,886

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2021-07-04
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2021-07-04
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2021-07-04
Aimmune Therapeutics, Inc. PALFORZIA peanut (arachis hypogaea) allergen powder Powder 125696 01/31/2020 ⤷  Try a Trial 2021-07-04
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.